Pfizer’s HYMPAVZI for Hemophilia A or B receives EU approval
The European Commission has approved Pfizer’s treatment for adults and adolescents with severe hemophilia A or B.
The European Commission has approved Pfizer’s treatment for adults and adolescents with severe hemophilia A or B.